The latest trading day saw Merck (MRK) settling at $119.28, representing a -1.3% change from its previous close.

The deal consideration is $53.00 per share in cash for an approximate equity value of $6.7 billion.

Two stocks retirement investors typically reach for in uncertain markets have risen notably in recent months.

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: TERN). On March 25, 2026, Merck announced that it had entered into a definitive agreement to acquire Terns. Upon the successful closing of the tender offer, stockholders of Terns will receive $53.00 net in cash for each share of Te.

Eli Lilly and peers like Novartis fuel a 2026 pharma M&A surge, striking billion-dollar deals to expand pipelines, tap AI innovation, and counter patent pressures.

Leo Wealth LLC increased its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 29.3% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 26,848 shares of the company's stock after buying an additional 6,078 shares during the quarter. Leo Wealth

Savvy Advisors Inc. grew its position in shares of Merck and Co., Inc. (NYSE: MRK) by 50.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 25,567 shares of the company's stock after buying an additional 8,627 shares during

The drugmaker's stock recently got a shot in the arm on the news of it acquiring Terns Pharmaceutical—a move that will not only bolster its cancer treatment pipeline but also reinforce Merck's role as a top-tier serial acquirer.

This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields 4.26%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 8%.

Analyst IMS Investment Management Services Ltd. boosted its stake in Merck and Co., Inc. (NYSE: MRK) by 301.5% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 10,298 shares of the company's stock after purchasing an additional 7,733 shares during the period. Analyst IMS Investment Management